The collaboration between Dr. Kingsley R. Chin and Aditya Humad led to the establishment of KIC and its subsidiary health technology holding company, KIC Ventures. Their shared vision focuses on lowering costs and minimizing risks, while ensuring superior outcomes for spine patients worldwide. Embodying the core values of Knowledge, Innovation, and Customer, they are dedicated to revolutionizing healthcare through continuous innovation.

​

Their commitment is evidenced by their portfolio companies, which include NANISX, a leader in outpatient spine surgery technologies, and NanoFuse Biologics, distinguished by its FDA approval for a unique combination of DBM and synthetic bioactive glass, acquired in 2018. Additionally, the acquisition of AxioMed in 2014, known for its viscoelastic disc replacement technology, showcases their dedication to advancing healthcare solutions.

​

They encourage investors, physicians, and patients to engage with their story, which is grounded in modest beginnings and holds the promise of significant global impact. This is an opportunity to join a journey that aims to position KIC Ventures as a transformative power in the global healthcare landscape.